Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study
Jonathan P. Piccini, Veronika Eder, Magdalena Benda, Helmut Pürerfellner(Krankenhaus der Elisabethinen), W. Schuyler Jones(Duke University), Stefan Stojković, Manesh R. Patel(Clinical Research Institute), Miriam Eber, Beatrix Mutschlechner, Peter Jirak(Paracelsus Medical University), Valeria Caso, Tobias Kolbitsch, Michael Derndorfer, Hardi Mundl(Roche (Switzerland)), Matthias Frick, Wilfried Schgoer, Lukas Sprenger, Christopher Adlbrecht, Alexandra Schratter, Maximilian Mächler, Keith A.A. Fox(University of Edinburgh), Uta C. Hoppe(Baker Heart and Diabetes Institute), Diana A. Gorog(University of Hertfordshire), Robert Schönbauer(Leipzig Heart Institute), Christoph Keil(Bayer (Germany)), Christoph Neumann(Bayer (Germany)), Johann Auer, Christian Ebner(University of Chicago), Martin Manninger-Wünscher, Thomas Viethen(Bayer (Germany)), Johannes Hajos, Jutta Bergler‐Klein, Markus Stühlinger(Innsbruck Medical University), Stuart J. Connolly(Population Health Research Institute), Ursula Rohrer, Jonas Oldgren, Václav Durdil(University Hospital in Motol), Michael Lichtenauer(Medical University of Vienna), Andreas Schober(Ludwig-Maximilians-Universität München), Dietmar Reitgruber, Eva Preishuber, Florian Schmalzer, Carina Primus-Grabscheit, Sead Pandzic, Martin Hubauer, Christoph H. Saely(Bayer (Germany)), Moritz Mirna(Paracelsus Medical University), Jana M. Schwarzl, Christian Hengstenberg(Medical University of Vienna)
Cited by 310
Related Papers
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
|European Heart Journal|2024|2.4k
Subclinical Atrial Fibrillation and the Risk of Stroke
|New England Journal of Medicine|2012|2.1k